This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Sources: Australasian College of Pharmacy. Management of reflux: a guideline for pharmacists. Queensland Health. Queensland Community Pharmacy Gastro-oesophageal Reflux and Gastro-oesophageal Reflux Disease – Clinical Practice Guideline. NSW Health. NSW Pharmacist Practice Standards for gastro-oesophageal reflux and gastro-oesophageal reflux disease.[/caption]
Dr Ming S Soh PhD, BPharm (Hons)[/caption]
DR Amy Page (she/her) PhD, MClinPharm, GradDipBiostat, GCertHProfEd, GAICD, GStat, FSHPA, FPS is a consultant pharmacist, biostatistician, and the director of the Centre for Optimisation of Medicines at UWA’s School of Allied Health.[/caption]
Hui Wen Quek (she/her) BPharm(Hons), GradCertAppPharmPrac is a pharmacist and PhD candidate at the University of Western Australia (UWA).[/caption]
Case scenario
Amir, a 35-year-old male, presents to the pharmacy requesting a salbutamol inhaler. Upon questioning, he informs you he needs salbutamol for his asthma and has ‘used it since he was a kid’. Amir says his asthma has been well controlled of late and that it only flares with a chest infection and when he gets hay fever. He states he would like to have the salbutamol as he is going away and wants to have one on hand. He is on no other asthma medicines and has only used salbutamol twice in the past month.
Learning objectivesAfter reading this article, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.2, 3.1, 3.5 Accreditation number: CAP2510CDMSB Accreditation expiry: 31/09/2028 |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Introduction
The Global Initiative for Asthma (GINA) strategy defines asthma as ‘a heterogeneous disease, usually characterised by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, together with variable expiratory airflow limitation’.1
In 2019, GINA comprehensively revised its recommendations for asthma management. This was based on its committee of asthma experts reviewing the evidence. Asthma guidelines from the National Asthma Council Australia
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
